| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -9,540 | -7,031 |
| Depreciation | 2,495 | 1,548 |
| Amortization of intangible assets | 625 | 417 |
| Equity-based compensation | 14,098 | 9,225 |
| Realized gain on sale of available-for-sale marketable securities | 16 | 16 |
| Accretion of discount on available-for-sale marketable securities | 635 | 460 |
| Unrealized foreign exchange gain | 1,123 | 1,669 |
| Remeasurement of marketable equity securities | 261 | 262 |
| Trade receivables, net | 12,224 | -948 |
| Prepaid expenses and other assets | 477 | 2,858 |
| Operating lease right-of-use assets | 1,849 | 1,166 |
| Accrued interest on bank deposits | -8 | 54 |
| Deferred tax, net | -99 | -283 |
| Trade payables | 442 | 466 |
| Deferred revenues | -547 | -387 |
| Accrued expenses and other payables | -920 | -1,393 |
| Accrued payroll and related benefits | -4,220 | -4,606 |
| Operating lease liability | -2,121 | -1,560 |
| Accrued severance pay, net | 64 | 64 |
| Net cash used in operating activities | -12,080 | -6,221 |
| Purchase of property and equipment | 1,428 | 1,002 |
| Proceeds from the sale of intrinsix | 3,470 | 3,470 |
| Asset acquisition-Ceva Technologies Single Member Private Company | 0 | 0 |
| Investment in bank deposits | 2,705 | 705 |
| Proceeds from bank deposits | 2,000 | 0 |
| Investment in available-for-sale marketable securities | 49,843 | 30,751 |
| Proceeds from maturity of available-for-sale marketable securities | 59,197 | 45,860 |
| Proceeds from sale of available-for-sale marketable securities | 3,914 | 3,914 |
| Net cash provided by (used in) investing activities | 14,605 | 20,786 |
| Purchase of treasury stock | 7,150 | 6,162 |
| Proceeds from exercise of stock-based awards | 3,224 | 1,630 |
| Net cash used in financing activities | -3,926 | -4,532 |
| Effect of exchange rate changes on cash and cash equivalents | 173 | 551 |
| Decrease in cash and cash equivalents | -1,228 | 10,584 |
| Cash and cash equivalents at beginning of period | 18,498 | - |
| Cash and cash equivalents at end of period | 17,270 | - |
CEVA INC (CEVA)
CEVA INC (CEVA)